Parkinson's Disease Treatments Market Report

Global and China Parkinson's Disease Treatments Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 04, 2022
  • PAGES：196
  • REPORT CODE：GMM1344892
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinson's Disease Treatments industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Abbvie

    • Wockhardt

    • Valeant Pharmaceuticals

    • Novartis

    • Acadia

    • Teva

    • UCB

    • Merck

    • GSK

    • Lundbeck

    • Boehringer Ingelheim

    • Sun Pharma

    • Impax

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Dopamine Agonists

    • Levodopa

    • Glutamate Antagonist

    • Apomorphine

    • COMT Inhibitors Anticholinergics

    • MAO-B Inhibitors

    • Other Drugs

    Application:

    • Hospitals

    • Healthcare Institutes

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Parkinson's Disease Treatments Industry Overview

      • 1.1.1 Parkinson's Disease Treatments Market Scope and Market Segments

      • 1.1.2 Parkinson's Disease Treatments Industry Characteristics

      • 1.1.3 Global and China Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Parkinson's Disease Treatments Production Value and Growth Rate (2017-2028)

    • 1.2 Global Parkinson's Disease Treatments Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Dopamine Agonists

      • 1.2.2 Levodopa

      • 1.2.3 Glutamate Antagonist

      • 1.2.4 Apomorphine

      • 1.2.5 COMT Inhibitors Anticholinergics

      • 1.2.6 MAO-B Inhibitors

      • 1.2.7 Other Drugs

    • 1.3 Global Parkinson's Disease Treatments Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Healthcare Institutes

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Parkinson's Disease Treatments Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Parkinson's Disease Treatments Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Parkinson's Disease Treatments Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Parkinson's Disease Treatments Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Parkinson's Disease Treatments Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Parkinson's Disease Treatments Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Parkinson's Disease Treatments Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Parkinson's Disease Treatments Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Parkinson's Disease Treatments Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Parkinson's Disease Treatments Industry Porter's Five Forces Model Analysis

      • 2.2.3 Parkinson's Disease Treatments Industry PEST Analysis

    • 2.3 Parkinson's Disease Treatments Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Parkinson's Disease Treatments Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Parkinson's Disease Treatments Industry

    Chapter 3 Global and China Parkinson's Disease Treatments Market, by Manufacturer

    • 3.1 Global and China Parkinson's Disease Treatments Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Parkinson's Disease Treatments Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Parkinson's Disease Treatments Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Parkinson's Disease Treatments Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Parkinson's Disease Treatments Market Top 3 Players

    Chapter 4 Global and China Parkinson's Disease Treatments Market, by Type (2017-2028)

    • 4.1 Parkinson's Disease Treatments Market Trend, by Type

    • 4.2 Global Parkinson's Disease Treatments Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Parkinson's Disease Treatments Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Parkinson's Disease Treatments Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Parkinson's Disease Treatments Price Trend, by Type (2017-2028)

    • 4.3 China Parkinson's Disease Treatments Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Parkinson's Disease Treatments Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Parkinson's Disease Treatments Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Parkinson's Disease Treatments Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Parkinson's Disease Treatments Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Parkinson's Disease Treatments Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Parkinson's Disease Treatments Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Parkinson's Disease Treatments Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Parkinson's Disease Treatments Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Parkinson's Disease Treatments Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Parkinson's Disease Treatments Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Parkinson's Disease Treatments Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Parkinson's Disease Treatments Market Analysis

    • 7.1 North America Parkinson's Disease Treatments Market, by Type

    • 7.2 North America Parkinson's Disease Treatments Market, by Application

    • 7.3 North America Parkinson's Disease Treatments Market Analysis and Forecast, by Country

      • 7.3.1 United States Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Parkinson's Disease Treatments Market Analysis

    • 8.1 Europe Parkinson's Disease Treatments Market, by Type

    • 8.2 Europe Parkinson's Disease Treatments Market, by Application

    • 8.3 Europe Parkinson's Disease Treatments Market Analysis and Forecast, by Country

      • 8.3.1 Germany Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Parkinson's Disease Treatments Market Analysis

    • 9.1 APAC Parkinson's Disease Treatments Market, by Type

    • 9.2 APAC Parkinson's Disease Treatments Market, by Application

    • 9.3 APAC Parkinson's Disease Treatments Market Analysis and Forecast, by Country

      • 9.3.1 China Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Parkinson's Disease Treatments Market Analysis

    • 10.1 Latin America, Middle East and Africa Parkinson's Disease Treatments Market, by Type

    • 10.2 Latin America, Middle East and Africa Parkinson's Disease Treatments Market, by Application

    • 10.3 Latin America, Middle East and Africa Parkinson's Disease Treatments Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Parkinson's Disease Treatments Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Parkinson's Disease Treatments Company Profiles

      • 11.1 Abbvie

        • 11.1.1 Abbvie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Abbvie Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.1.3 Abbvie Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Wockhardt

        • 11.2.1 Wockhardt Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Wockhardt Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.2.3 Wockhardt Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Valeant Pharmaceuticals

        • 11.3.1 Valeant Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Valeant Pharmaceuticals Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.3.3 Valeant Pharmaceuticals Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Novartis

        • 11.4.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Novartis Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.4.3 Novartis Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Acadia

        • 11.5.1 Acadia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Acadia Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.5.3 Acadia Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Teva

        • 11.6.1 Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Teva Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.6.3 Teva Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 UCB

        • 11.7.1 UCB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 UCB Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.7.3 UCB Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Merck

        • 11.8.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Merck Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.8.3 Merck Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 GSK

        • 11.9.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 GSK Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.9.3 GSK Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Lundbeck

        • 11.10.1 Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Lundbeck Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.10.3 Lundbeck Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Boehringer Ingelheim

        • 11.11.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Boehringer Ingelheim Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.11.3 Boehringer Ingelheim Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Sun Pharma

        • 11.12.1 Sun Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Sun Pharma Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.12.3 Sun Pharma Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Impax

        • 11.13.1 Impax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Impax Parkinson's Disease Treatments Product Profiles, Application and Specification

        • 11.13.3 Impax Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Parkinson's Disease Treatments Industry Investment Prospect and Risk Assessment

    • 12.1 Parkinson's Disease Treatments Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Parkinson's Disease Treatments Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Treatments Production Value and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Treatments Production Value and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of Dopamine Agonists (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of Levodopa (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of Glutamate Antagonist (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of Apomorphine (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of COMT Inhibitors Anticholinergics (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of MAO-B Inhibitors (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of Other Drugs (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of Healthcare Institutes (2017-2028)

    • Figure Global Parkinson's Disease Treatments Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Parkinson's Disease Treatments Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Parkinson's Disease Treatments Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Parkinson's Disease Treatments Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Treatments Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Treatments Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Parkinson's Disease Treatments Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Parkinson's Disease Treatments Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease Treatments Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease Treatments Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Parkinson's Disease Treatments Market Share, by Manufacturer in 2021

    • Figure Global and China Parkinson's Disease Treatments Market Share, by Manufacturer in 2022

    • Table Global Parkinson's Disease Treatments Sales Volume, by Type (2017-2028)

    • Table Global Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Table Global Parkinson's Disease Treatments Sales Value, by Type (2017-2028)

    • Table Global Parkinson's Disease Treatments Sales Value Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease Treatments Price Trend, by Type (2017-2028)

    • Table China Parkinson's Disease Treatments Sales Volume, by Type (2017-2028)

    • Table China Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Figure China Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Table China Parkinson's Disease Treatments Sales Value, by Type (2017-2028)

    • Table China Parkinson's Disease Treatments Sales Value Share, by Type (2017-2028)

    • Figure China Parkinson's Disease Treatments Price Trend, by Type (2017-2028)

    • Table Global Parkinson's Disease Treatments Sales Volume, by Application (2017-2028)

    • Table Global Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Table Global Parkinson's Disease Treatments Sales Value, by Application (2017-2028)

    • Table Global Parkinson's Disease Treatments Sales Value Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease Treatments Sales Value Share, by Application (2017-2028)

    • Table China Parkinson's Disease Treatments Sales Volume, by Application (2017-2028)

    • Table China Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Table China Parkinson's Disease Treatments Sales Value, by Application (2017-2028)

    • Table China Parkinson's Disease Treatments Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Treatments Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • Figure North America Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Treatments Production, Import, Consumption and Export (2017-2022)

    • Table North America Parkinson's Disease Treatments Sales Volume, by Type (2017-2028)

    • Table North America Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Figure North America Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Table North America Parkinson's Disease Treatments Sales Volume, by Application (2017-2028)

    • Table North America Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure North America Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure United States Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure United States Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Table Europe Parkinson's Disease Treatments Sales Volume, by Type (2017-2028)

    • Table Europe Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Figure Europe Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Table Europe Parkinson's Disease Treatments Sales Volume, by Application (2017-2028)

    • Table Europe Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure Europe Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure Germany Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Table APAC Parkinson's Disease Treatments Sales Volume, by Type (2017-2028)

    • Table APAC Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Figure APAC Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Table APAC Parkinson's Disease Treatments Sales Volume, by Application (2017-2028)

    • Table APAC Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure APAC Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Treatments Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Treatments Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Treatments Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Treatments Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease Treatments Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease Treatments Sales Value and Growth Rate (2017-2028)

    • Table Abbvie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbvie Product Profiles, Application and Specification

    • Table Abbvie Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Wockhardt Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Wockhardt Product Profiles, Application and Specification

    • Table Wockhardt Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Acadia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Acadia Product Profiles, Application and Specification

    • Table Acadia Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Product Profiles, Application and Specification

    • Table Teva Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table UCB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table UCB Product Profiles, Application and Specification

    • Table UCB Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lundbeck Product Profiles, Application and Specification

    • Table Lundbeck Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sun Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sun Pharma Product Profiles, Application and Specification

    • Table Sun Pharma Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Impax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Impax Product Profiles, Application and Specification

    • Table Impax Parkinson's Disease Treatments Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US